Generate Biomedicines, Inc. (GENB)

Last Closing Price: 14.49 (2026-06-18)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Generate Biomedicines, Inc. (GENB) Stock-Based Compensation data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-1.07
-1.07
Balance Sheet Financials
--
--
--
0.00M
--
--
--
--
--
--
--
--
Cash Flow Statement Financials
--
--
--
--
--
--
Stock-Based Compensation
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--